Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis.
<h4>Background</h4>Evaluation of cystic fibrosis transmembrane conductance regulator (CFTR) functional activity to assess new therapies and define diagnosis of cystic fibrosis (CF) is cumbersome. It is known that leukocytes express detectable levels of CFTR but the molecule has not been...
Guardado en:
Autores principales: | Claudio Sorio, Mario Buffelli, Chiara Angiari, Michele Ettorre, Jan Johansson, Marzia Vezzalini, Laura Viviani, Mario Ricciardi, Genny Verzè, Baroukh Maurice Assael, Paola Melotti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c7611f813b1c43cb89b911095a1eea52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
por: Maite Calucho, et al.
Publicado: (2021) -
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
por: Iwona M. Pranke, et al.
Publicado: (2017) -
CFTR mutations spectrum and the efficiency of molecular diagnostics in Polish cystic fibrosis patients.
por: Ewa Ziętkiewicz, et al.
Publicado: (2014) -
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
por: Serena Schippa, et al.
Publicado: (2013) -
ACTIVATION AND DIFFERENTIATION OF PERIPHERAL BLOOD MONOCYTES IN PERIODONTITIS
por: L. M. Tebloeva, et al.
Publicado: (2014)